# Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter

> **NCT04141553** · PHASE4 · UNKNOWN · sponsor: **Mercy Health Muskegon** · enrollment: 300 (estimated)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter
- Rapid Ventricular Response

## Interventions

- **DRUG:** Diltiazem Injection

## Key facts

- **NCT ID:** NCT04141553
- **Lead sponsor:** Mercy Health Muskegon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04141553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04141553, "Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04141553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*